A guardian dog has taken energetic measures against a large number of weight loss soap suppliers to announce prescription medications to the public.
The Advertising Standards Authority (ASA) said that the nine failures against the ads, one with reality shows, Gemma Collins, made it “crystalline” that all the injectable forms of medicines for weight loss were only recipes and, therefore, could not be announced to the public.
In December, the ASA warned companies and individuals who were attacked to public members with advertisements for medicines.
He said that no one operates in the industry could say that they had not been warned that the medications prescribed weight loss “should not be promoted to the public.”
The prohibited ads include an Instagram post of Collins, published on January 6, which promoted the Yazen weight loss service.
In a video, Collins declared: “I am starting this year two sizes, thanks to the application of Yazen's weight loss and medication. It is really fast and easy to start with Yazen, my life has changed absolutely … I finally found something I really lose weight.”
She continued: “Yes, there are, you know, reports and those things. And I don't tell anyone to perform this medication, but it is prescribed in the NHS.”
Two plaintiffs questioned if the announcement violated the rules because it promoted the medicine only with recipe to the public.
Yazen said that the post had intended to share information about his “holistic approach and responsible for weight loss”, and that he did not intend to focus solely on medicines.
After the notification of the complaint, and according to Collins, the post has been modified to eliminate any reference to medications only with recipe.
Yazen said they would ensure that future publications complied with the advertising code.
Collins said his responsibilities under the advertising code was taken seriously and struggled to fulfill them.
He accepted that his publications had promoted the service and the application of weight loss Yazen, and said that they would approve any marketing material that could publish in the future, and would follow any guide that the handle provided.
The ASA also prohibited an advertisement for medications for the weight loss of prescription published by Méchp, which said: “There is no GP or visit to the pharmacy, only an online consultation of 2 minutes.”
Chequp told the handle that they believed that the announcement had been created in line with what had become a generalized practice of the industry in the weight loss sector.
They assured the handle that the announcement would not appear again.
Other suppliers to those who have had their ads include Pharmacyonline.co.uk, Healthexpress.co.uk, Juniper UK, Cloud Pharmacy and Phlo Clinic and Semapen.
The ASA said the decisions established drug advertising with a name with name such as Wegovy, Mounjaro, Ozempic and Saxenda were prohibited, as well as the use of various statements such as “obesity treatment jab” and “weight loss pen”.
In April, the ASA said a search in January found around 1,800 unique advertisements of paid weight loss that identified as potentially announcing a medicine only with a recipe.
He has published a joint application notice with the Health and Products Regulatory Agency and the General Council of Pharmaceutical, making it clear that advertisements for medications with a weight loss recipe are prohibited, included online, on social networks and by influential people.
